Announcements

Riffyn Launches Process Design and Data Analytics Software at SynBioBeta 2016

Timothy Gardner

SAN FRANCISCO, CA - Riffyn announced today the launch of its cloud-based research process design software at the SynBioBeta SF 2016 conference. The launch follows a successful beta trial period, in which more than 40 organizations participated. Riffyn’s product delivers a step-change in the pace and quality of research and development in the life science, chemical, and food industries – supporting organizations from early-stage discovery to manufacturing development.

“Riffyn represents the synthesis of our decades of scientific and engineering experience into an elegant software platform for individual scientists and global organizations,” said Tim Gardner, Riffyn’s founder and CEO. "Riffyn’s unique computer-aided design and analytics transforms the reliability and speed of scientific R&D.”

As widely recognized in recent years, low experimental reproducibility and barriers to collaboration are diminishing impact of scientific R&D. Globally, these issues cost more than $100B annually in wasted effort and delayed commercialization – problems solved by Riffyn’s capabilities.

As part of the SynBioBeta conference, Riffyn is exhibiting the software live to attendees and arranging for private demonstrations. Additionally, Dr. Gardner will be presenting a lightning talk on October 5 at 4:10PM (Session 12).

About Riffyn

Riffyn’s cloud-based software provides computer-aided process design and advanced data analytics to R&D organizations. Riffyn delivers unprecedented data quality and real-time collaboration capabilities for reproducible discoveries and robust product development. The company was founded in 2014 by veterans from the life science and high-performance computing industries, and is headquartered in Oakland, California. To learn more about Riffyn please visit www.Riffyn.com.

Timothy Gardner's photo

Timothy Gardner

Tim Gardner is the Founder and the CEO of Riffyn. He was previously Vice President of Research & Development at Amyris, where he led the engineering of yeast strain and processes technology for large-scale bio-manufacturing of renewable chemicals. Tim has been recognized for his pioneering work in Synthetic Biology by Scientific American, the New Scientist, Nature, Technology Review, and the New York Times. He also served as an advisor to the European Union Scientific Committees and the Boston University Engineering Alumni Advisory Board. Tim enjoys hockey, running, mountain biking, and being beaten by his sons in almost everything.